Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
208,541,052
-
Share change
-
+1,560,555
-
Total reported value
-
$8,032,573,648
-
Put/Call ratio
-
96%
-
Price per share
-
$38.51
-
Number of holders
-
756
-
Value change
-
+$51,491,334
-
Number of buys
-
263
-
Number of sells
-
399
Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q4 2016
As of 31 Dec 2016,
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) was held by
756 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
208,541,052 shares.
The largest 10 holders included
FMR LLC, Fisher Asset Management, LLC, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, Bank of New York Mellon Corp, BANK OF AMERICA CORP /DE/, and MORGAN STANLEY.
This page lists
756
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.